Artificial Intelligence Predicts Next Session’s Price Change For Baidu, Graham Holdings Company, Medtronic

(VIANEWS) – Today, the AICapitalize artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Baidu BIDU, Graham Holdings Company GHC and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

AICapitalize provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

AICapitalize officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

Financial Asset Accuracy Close Price Prediction
Baidu (BIDU) 98.22% $118.34 $118.37
Graham Holdings Company (GHC) 94.37% $685.24 $694.3
Medtronic (MDT) 93.65% $83.61 $85.15
Johnson & Johnson (JNJ) 93.39% $161.1 $164.59
Phillips 66 (PSX) 93.34% $135.33 $139.5
Alnylam Pharmaceuticals (ALNY) 93.33% $189.12 $194.5
TransCanada (TRP) 93.3% $39.7 $40.5
Eli Lilly and Company (LLY) 93.3% $624.13 $636.16
General Mills (GIS) 93.19% $66.21 $67.57
American Airlines (AAL) 93.19% $13.18 $12.54
ONEOK (OKE) 89.31% $71.36 $72.23
SK Telecom (SKM) 89.27% $20.91 $20.93
Hartford Financial Services Group (HIG) 89.22% $82.63 $82.83
Interactive Brokers Group (IBKR) 89.11% $87.05 $88.14
Charter Comm (CHTR) 89.1% $375.93 $379.22
Colgate-Palmolive (CL) 89.09% $80.5 $81.58
GlaxoSmithKline (GSK) 88.83% $39.08 $39.55
Laboratory Corporation of America Holdings (LH) 88.66% $226.23 $232.28
Pfizer (PFE) 88.59% $29.16 $29.75
Biogen (BIIB) 88.5% $260.27 $267.26
Gilead Sciences (GILD) 88.48% $84.38 $86.31
The Travelers Companies (TRV) 88.42% $193.58 $196.92
Tyson Foods (TSN) 88.4% $54.2 $55.53
Yelp (YELP) 88.29% $46.54 $46.66
Raymond James Financial (RJF) 88.16% $110.53 $113.7
Fastly (FSLY) 87.83% $16.3 $16.24
Unilever (UL) 87.71% $48.83 $50.31
Energy Transfer (ET) 84.4% $13.96 $14.03
LyondellBasell (LYB) 84.39% $96.41 $97.63
Fox Corporation (FOXA) 84.15% $30.08 $30.3
KeyCorp (KEY) 84.1% $14.44 $14.51
Internationa Flavors & Fragrances (IFF) 83.84% $79.58 $81.48
Novartis AG (NVS) 83.74% $105.4 $106.85
Public Service Enterprise Group (PEG) 83.74% $61.94 $62.98
Southern Company (SO) 83.72% $72.16 $73.44

1. Baidu (BIDU)

Shares of Baidu jumped 2.98% in from $114.92 to $118.34 at 18:21 EST on Thursday, following the last session’s upward trend. NASDAQ is falling 0.56% to $14,510.30, after four successive sessions in a row of losses.

Baidu, Inc. offers internet search services in China. It operates through Baidu Core and iQIYI segments. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Baidu Health that helps users to find the doctor and hospital for healthcare needs; and Haokan, a short video app. It also provides Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Experience; Baidu Post; Baidu Wenku; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, it offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Further, the company provides iQIYI, an online entertainment service, including original and licensed content; other video content and membership; and online advertising services. Baidu, Inc. has strategic partnership with Zhejiang Geely Holding Group. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.

Moving Average

Baidu’s worth is above its 50-day moving average of $112.19 and below its 200-day moving average of $130.24.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 13.9% and 7.1%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Baidu’s stock is considered to be overbought (>=80).

More news about Baidu.

2. Graham Holdings Company (GHC)

Shares of Graham Holdings Company rose 7.98% in from $634.6 to $685.24 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company in the United States and internationally. It provides test preparation services and materials; professional training and exam preparation for professional certifications and licensures; and non-academic operations support services to the Purdue University Global; operations support services for online courses and programs; training and test preparation services for accounting and financial services professionals; English-language training, academic preparation programs, and test preparation for English proficiency exams; and A-level examination preparation services, as well as operates colleges, business school, higher education institution, and an online learning institution. The company also owns and operates television stations, restaurants, and entertainment venues; engages in the financial training and automobile dealerships business; offers social media management tools to connect newsrooms with their users; produces Foreign Policy magazine and ForeignPolicy.com website; and publishes Slate, an online magazine, as well as French-language news magazine websites at slate.fr and slateafrique.com. In addition, it provides social media marketing solutions; home health, hospice, and palliative services; burners, igniters, dampers, and controls; screw jacks, linear actuators, and related linear motion products, and lifting systems; pressure impregnated kiln-dried lumber and plywood products; digital advertising services; power charging and data systems, industrial and commercial indoor lighting solutions, and electrical components and assemblies; dermatology and professional aesthetics, and skin care services; software and services; and operates pharmacy. The company was formerly known as The Washington Post Company and changed its name to Graham Holdings Company in November 2013. Graham Holdings Company was founded in 1877 and is based in Arlington, Virginia.

More news about Graham Holdings Company.

3. Medtronic (MDT)

Shares of Medtronic jumped 6.35% in from $78.62 to $83.61 at 18:21 EST on Thursday, after four successive sessions in a row of gains. NYSE is dropping 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Yearly Top and Bottom Value

Medtronic’s stock is valued at $83.61 at 18:21 EST, below its 52-week high of $92.02 and way above its 52-week low of $68.84.

Volatility

Medtronic’s last week, last month’s, and last quarter’s current intraday variation average was 0.07%, 0.20%, and 0.98%.

Medtronic’s highest amplitude of average volatility was 0.49% (last week), 0.82% (last month), and 0.98% (last quarter).

More news about Medtronic.

4. Johnson & Johnson (JNJ)

Shares of Johnson & Johnson jumped 2.72% in from $156.83 to $161.10 at 18:21 EST on Thursday, after five sequential sessions in a row of gains. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Volatility

Johnson & Johnson’s last week, last month’s, and last quarter’s current intraday variation average was 1.08%, 0.04%, and 0.71%.

Johnson & Johnson’s highest amplitude of average volatility was 1.08% (last week), 0.67% (last month), and 0.71% (last quarter).

Moving Average

Johnson & Johnson’s worth is higher than its 50-day moving average of $152.54 and higher than its 200-day moving average of $159.49.

More news about Johnson & Johnson.

5. Phillips 66 (PSX)

Shares of Phillips 66 rose 7.44% in from $125.96 to $135.33 at 18:21 EST on Thursday, after three sequential sessions in a row of gains. NYSE is dropping 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Phillips 66 operates as an energy manufacturing and logistics company in the United States, the United Kingdom, Germany, and internationally. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks; delivers refined petroleum products to market; provides terminaling and storage services for crude oil and refined petroleum products; transports, stores, fractionates, exports, and markets natural gas liquids; provides other fee-based processing services; and gathers, processes, transports, and markets natural gas. The Chemicals segment produces and markets ethylene and other olefin products; aromatics and styrenics products, such as benzene, cyclohexane, styrene, and polystyrene; and various specialty chemical products, including organosulfur chemicals, solvents, catalysts, and chemicals used in drilling and mining. The Refining segment refines crude oil and other feedstocks into petroleum products, such as gasolines, distillates, aviation, and renewable. The M&S segment purchases for resale and markets refined petroleum products, including gasolines, distillates, and aviation fuels. This segment also manufactures and markets specialty products, such as base oils and lubricants. The company was founded in 1875 and is headquartered in Houston, Texas.

Previous days news about Phillips 66

  • Phillips 66 (psx) rises as market takes a dip: key facts. According to Zacks on Tuesday, 2 January, "Market participants will be closely following the financial results of Phillips 66 in its upcoming release. ", "In terms of valuation, Phillips 66 is presently being traded at a Forward P/E ratio of 10.2. "
  • Why the market dipped but phillips 66 (psx) gained today. According to Zacks on Wednesday, 3 January, "In the latest market close, Phillips 66 (PSX Quick QuotePSX – Free Report) reached $135.75, with a +1.09% movement compared to the previous day. ", "In terms of valuation, Phillips 66 is presently being traded at a Forward P/E ratio of 10.29. "

More news about Phillips 66.

6. Alnylam Pharmaceuticals (ALNY)

Shares of Alnylam Pharmaceuticals jumped 8.62% in from $174.11 to $189.12 at 18:21 EST on Thursday, following the last session’s downward trend. NASDAQ is falling 0.56% to $14,510.30, after four successive sessions in a row of losses.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

More news about Alnylam Pharmaceuticals.

7. TransCanada (TRP)

Shares of TransCanada rose 4.47% in from $38 to $39.70 at 18:21 EST on Thursday, after two sequential sessions in a row of gains. NYSE is sliding 0.02% to $16,715.71, after four consecutive sessions in a row of losses.

TC Energy Corporation operates as an energy infrastructure company in North America. It operates through five segments: Canadian Natural Gas Pipelines; U.S. Natural Gas Pipelines; Mexico Natural Gas Pipelines; Liquids Pipelines; and Power and Energy Solutions. The company builds and operates a network of 93,700 kilometers of natural gas pipelines, which transports natural gas from supply basins to local distribution companies, power generation plants, industrial facilities, interconnecting pipelines, LNG export terminals, and other businesses. It also has regulated natural gas storage facilities with a total working gas capacity of 532 billion cubic feet. In addition, it has approximately 4,900 kilometers of liquids pipeline system that connects Alberta crude oil pipeline to refining markets in Illinois, Oklahoma, and Texas. Further, the company owns or has interests in seven power generation facilities with a combined capacity of approximately 4,300 megawatts that are powered by natural gas and nuclear fuel sources located in Alberta, Ontario, Québec, and New Brunswick; and owns and operates approximately 118 billion cubic feet of non-regulated natural gas storage capacity in Alberta. The company was formerly known as TransCanada Corporation and changed its name to TC Energy Corporation in May 2019. TC Energy Corporation was incorporated in 1951 and is headquartered in Calgary, Canada.

Volatility

TransCanada’s last week, last month’s, and last quarter’s current intraday variation average was 0.16%, 0.16%, and 0.90%.

TransCanada’s highest amplitude of average volatility was 0.34% (last week), 0.83% (last month), and 0.90% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 1.2% and a drop 6.6% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 27.2%, now sitting on 13.73B for the twelve trailing months.

More news about TransCanada.

8. Eli Lilly and Company (LLY)

Shares of Eli Lilly and Company jumped 5.85% in from $589.64 to $624.13 at 18:21 EST on Thursday, after three consecutive sessions in a row of gains. NYSE is dropping 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Sales Growth

Eli Lilly and Company’s sales growth is 22.5% for the present quarter and 22.5% for the next.

Yearly Top and Bottom Value

Eli Lilly and Company’s stock is valued at $624.13 at 18:21 EST, below its 52-week high of $629.97 and way above its 52-week low of $309.20.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 33.5% and 56.8%, respectively.

More news about Eli Lilly and Company.

9. General Mills (GIS)

Shares of General Mills rose 0.26% in from $66.04 to $66.21 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is falling 0.02% to $16,715.71, after four sequential sessions in a row of losses.

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates through four segments: North America Retail; International; Pet; and North America Foodservice. It offers grain, ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream and frozen desserts, nutrition bars, and savory snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Kitano, Kix, Lärabar, Latina, Lucky Charms, Muir Glen, Nature Valley, Nudges, Oatmeal Crisp, Old El Paso, Pillsbury, Progresso, Raisin Nut Bran, Total, Top Chews Naturals, Totino's, Trix, True Chews, Wanchai Ferry, Wheaties, Wilderness, Yoki, Reese's Puffs, Green Giant, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. In addition, the company operates ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.6%, now sitting on 20.2B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, General Mills’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 7.2% and a drop 0.9% for the next.

More news about General Mills.

10. American Airlines (AAL)

Shares of American Airlines slid 3.79% in from $13.7 to $13.18 at 18:21 EST on Thursday, after five sequential sessions in a row of losses. NASDAQ is dropping 0.56% to $14,510.30, after four successive sessions in a row of losses.

Here's why investors should buy American Airlines (aal) stock nowSolid Rank & VGM Score: American Airlines currently carries a Zacks Rank #2 (Buy) and has a VGM Score of A. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities. , Positive Earnings Surprise History: American Airlines has an impressive earnings surprise history.

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. As of December 31, 2022, it operated a mainline fleet of 925 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 52.91B for the twelve trailing months.

Moving Average

American Airlines’s worth is higher than its 50-day moving average of $12.63 and under its 200-day moving average of $14.24.

Yearly Top and Bottom Value

American Airlines’s stock is valued at $13.18 at 18:21 EST, way below its 52-week high of $19.08 and way higher than its 52-week low of $10.86.

More news about American Airlines.

11. ONEOK (OKE)

Shares of ONEOK rose 3.53% in from $68.93 to $71.36 at 18:21 EST on Thursday, after two successive sessions in a row of gains. NYSE is dropping 0.02% to $16,715.71, after four consecutive sessions in a row of losses.

ONEOK, Inc. engages in gathering, processing, fractionation, storage, transportation, and marketing of natural gas and natural gas liquids (NGL) in the United States. It operates through four segments: Natural Gas Gathering and Processing, Natural Gas Liquids, Natural Gas Pipelines, and Refined Products and Crude. The company owns natural gas gathering pipelines and processing plants in the Mid-Continent and Rocky Mountain regions. It also provides midstream services to producers of NGLs. The company owns NGL gathering and distribution pipelines in Oklahoma, Kansas, Texas, New Mexico, Montana, North Dakota, Wyoming, and Colorado; terminal and storage facilities in Kansas, Missouri, Nebraska, Iowa, and Illinois; NGL distribution pipelines in Kansas, Missouri, Nebraska, Iowa, Illinois, and Indiana; and transports refined petroleum products, including unleaded gasoline and diesel from Kansas to Iowa, as well as owns and operates truck- and rail-loading, and -unloading facilities connected to NGL fractionation, storage, and pipeline assets. In addition, it transports and stores natural gas through regulated interstate and intrastate natural gas transmission pipelines, and natural gas storage facilities. Further, the company owns and operates a parking garage in downtown Tulsa, Oklahoma; and leases excess office space and rail cars. Additionally, it transports, stores, and distributes refined products, NGLs, and crude oil, as well as conducts commodity-related activities, including liquids blending, fractionation, and marketing activities. It serves integrated and independent exploration and production companies; NGL and natural gas gathering and processing companies; crude oil and natural gas production companies; utilities; industrial companies; propane distributors; municipalities; ethanol producers; and petrochemical, refining, and NGL marketing companies. ONEOK, Inc. was founded in 1906 and is headquartered in Tulsa, Oklahoma.

More news about ONEOK.

12. SK Telecom (SKM)

Shares of SK Telecom dropped 3.49% in from $21.67 to $20.91 at 18:21 EST on Thursday, after five successive sessions in a row of losses. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

SK Telecom Co., Ltd. provides wireless telecommunication services in South Korea. The company operates through three segments: Cellular Services, Fixed-Line Telecommunications Services, and Other Businesses. The Cellular Services segment offers wireless voice and data transmission, Internet of Things solutions, platform, cloud, smart factory solutions, subscription, advertising and curated shopping under T Deal brand name, and metaverse platform-based services, as well as sells wireless devices. The Fixed-Line Telecommunications Services segment provides fixed-line telephone services; broadband Internet services; media platform services, such as Internet protocol TV and cable TV; and business communications services. The Other Businesses segment offers T-commerce services, as well as portal services under Nate brand name. In addition, it provides call center management, base station maintenance, information gathering and consulting, database and internet website, cable broadcasting, broadcasting programs, and digital contents sourcing services; manufactures non-memory and other electronic integrated circuits; international telecommunication and mobile; and operates information and communications facilities, and mobile virtual network, as well as engages in communications and communication device retail business. SK Telecom Co., Ltd. was incorporated in 1984 and is headquartered in Seoul, South Korea.

Yearly Top and Bottom Value

SK Telecom’s stock is valued at $20.91 at 18:21 EST, under its 52-week high of $22.61 and way higher than its 52-week low of $18.26.

Moving Average

SK Telecom’s worth is below its 50-day moving average of $21.28 and above its 200-day moving average of $20.52.

More news about SK Telecom.

13. Hartford Financial Services Group (HIG)

Shares of Hartford Financial Services Group rose 5.44% in from $78.37 to $82.63 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.02% to $16,715.71, after four consecutive sessions in a row of losses.

The Hartford Financial Services Group, Inc. provides insurance and financial services to individual and business customers in the United States, the United Kingdom, and internationally. Its Commercial Lines segment offers insurance coverages, including workers' compensation, property, automobile, general and professional liability, package business, umbrella, fidelity and surety, marine, livestock, and reinsurance through regional offices, branches, sales and policyholder service centers, independent retail agents and brokers, wholesale agents, and reinsurance brokers. The company's Personal Lines segment provides automobile, homeowners, and personal umbrella coverages through direct-to-consumer channel and independent agents. Its Property & Casualty Other Operations segment offers coverage for asbestos and environmental exposures. The company's Group Benefits segment provides group life, disability, and other group coverages to members of employer groups, associations, and affinity groups through direct insurance policies; reinsurance to other insurance companies; employer paid and voluntary product coverages; disability underwriting, administration, and claims processing to self-funded employer plans; and a single-company leave management solution. This segment distributes its group insurance products and services through brokers, consultants, third-party administrators, trade associations, and private exchanges. Its Hartford Funds segment offers managed mutual funds across various asset classes; and exchange-traded products through broker-dealer organizations, independent financial advisers, defined contribution plans, financial consultants, bank trust groups, and registered investment advisers, as well as investment management, distribution, and administrative services, such as product design, implementation, and oversight. The company was founded in 1810 and is headquartered in Hartford, Connecticut.

More news about Hartford Financial Services Group.

14. Interactive Brokers Group (IBKR)

Shares of Interactive Brokers Group rose 8.33% in from $80.36 to $87.05 at 18:21 EST on Thursday, after two sequential sessions in a row of gains. NASDAQ is sliding 0.56% to $14,510.30, after four consecutive sessions in a row of losses.

Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 18.5% and 16.3%, respectively.

Yearly Top and Bottom Value

Interactive Brokers Group’s stock is valued at $87.05 at 18:21 EST, below its 52-week high of $95.59 and way higher than its 52-week low of $70.83.

More news about Interactive Brokers Group.

15. Charter Comm (CHTR)

Shares of Charter Comm jumped 2.19% in from $367.87 to $375.93 at 18:21 EST on Thursday, following the last session’s downward trend. NASDAQ is falling 0.56% to $14,510.30, after four consecutive sessions in a row of losses.

Charter Communications, Inc. operates as a broadband connectivity and cable operator company serving residential and commercial customers in the United States. The company offers subscription-based internet, video, and mobile and voice services; a suite of broadband connectivity services, including fixed internet, WiFi, and mobile; security suite that protects computers from viruses and spyware, and threats from malicious actors; in-home WiFi, which provides customers with high performance wireless routers and managed WiFi services to enhance their fixed wireless internet experience; out-of-home WiFi; and Spectrum WiFi services. The company also offers voice communications services using voice over internet protocol technology; and broadband communications solutions, such as internet access, data networking, fiber connectivity, video entertainment, and business telephone services to cellular towers and office buildings for business and carrier organizations. In addition, it provides mobile services; video programming, static IP and business WiFi, and e-mail and security services; sells local advertising across various platforms for networks, such as TBS, CNN, and ESPN; sells advertising inventory to local sports and news channels; and offers Audience App to create data-driven linear TV campaigns for local advertisers. Further, the company offers communications products and managed service solutions; data connectivity services to mobile and wireline carriers on a wholesale basis; and owns and operates regional sports and news networks. It serves approximately 32 million customers in 41 states. The company was founded in 1993 and is headquartered in Stamford, Connecticut.

Volatility

Charter Comm’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.11%, a negative 0.12%, and a positive 1.51%.

Charter Comm’s highest amplitude of average volatility was 0.84% (last week), 1.59% (last month), and 1.51% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 14% and 18%, respectively.

More news about Charter Comm.

16. Colgate-Palmolive (CL)

Shares of Colgate-Palmolive jumped 3.79% in from $77.56 to $80.50 at 18:21 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is dropping 0.02% to $16,715.71, after four successive sessions in a row of losses.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 19.14B for the twelve trailing months.

Sales Growth

Colgate-Palmolive’s sales growth is 5.4% for the current quarter and 2.6% for the next.

Yearly Top and Bottom Value

Colgate-Palmolive’s stock is valued at $80.50 at 18:21 EST, below its 52-week high of $82.09 and way above its 52-week low of $67.62.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Colgate-Palmolive’s stock is considered to be oversold (<=20).

More news about Colgate-Palmolive.

17. GlaxoSmithKline (GSK)

Shares of GlaxoSmithKline rose 7.84% in from $36.24 to $39.08 at 18:21 EST on Thursday, after two successive sessions in a row of gains. NYSE is sliding 0.02% to $16,715.71, after four sequential sessions in a row of losses.

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GlaxoSmithKline’s stock is considered to be oversold (<=20).

Moving Average

GlaxoSmithKline’s worth is higher than its 50-day moving average of $35.71 and higher than its 200-day moving average of $35.70.

Sales Growth

GlaxoSmithKline’s sales growth is 10.7% for the current quarter and 6.4% for the next.

Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $39.08 at 18:21 EST, higher than its 52-week high of $38.32.

More news about GlaxoSmithKline.

18. Laboratory Corporation of America Holdings (LH)

Shares of Laboratory Corporation of America Holdings rose 3.74% in from $218.07 to $226.23 at 18:21 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is dropping 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Laboratory Corporation of America Holdings’s stock is considered to be oversold (<=20).

More news about Laboratory Corporation of America Holdings.

19. Pfizer (PFE)

Shares of Pfizer rose 0.31% in from $29.07 to $29.16 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.02% to $16,715.71, after four consecutive sessions in a row of losses.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Previous days news about Pfizer

  • Pfizer (pfe) flat as market sinks: what you should know. According to Zacks on Wednesday, 3 January, "With respect to valuation, Pfizer is currently being traded at a Forward P/E ratio of 13.32. "

More news about Pfizer.

20. Biogen (BIIB)

Shares of Biogen jumped by a staggering 10.67% in from $235.18 to $260.27 at 18:21 EST on Thursday, following the last session’s downward trend. NASDAQ is dropping 0.56% to $14,510.30, after four successive sessions in a row of losses.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It also provides RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, immunology related diseases, neurovascular disorders, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. Biogen Inc. has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 22% and positive 0.9% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 9.99B for the twelve trailing months.

Sales Growth

Biogen’s sales growth is negative 3.2% for the ongoing quarter and 1.8% for the next.

Previous days news about Biogen

  • Biogen inc. (biib) sees a more significant dip than broader market: some facts to know. According to Zacks on Wednesday, 3 January, "The upcoming earnings release of Biogen Inc. will be of great interest to investors. ", "It is also important to note the recent changes to analyst estimates for Biogen Inc. These revisions help to show the ever-changing nature of near-term business trends. "

More news about Biogen.

21. Gilead Sciences (GILD)

Shares of Gilead Sciences jumped 6.13% in from $79.51 to $84.38 at 18:21 EST on Thursday, after two sequential sessions in a row of gains. NASDAQ is dropping 0.56% to $14,510.30, after four successive sessions in a row of losses.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was incorporated in 1987 and is headquartered in Foster City, California.

Yearly Top and Bottom Value

Gilead Sciences’s stock is valued at $84.38 at 18:21 EST, below its 52-week high of $88.29 and way higher than its 52-week low of $72.87.

Volatility

Gilead Sciences’s last week, last month’s, and last quarter’s current intraday variation average was 1.30%, 0.32%, and 1.10%.

Gilead Sciences’s highest amplitude of average volatility was 1.46% (last week), 1.11% (last month), and 1.10% (last quarter).

More news about Gilead Sciences.

22. The Travelers Companies (TRV)

Shares of The Travelers Companies rose 5.59% in from $183.33 to $193.58 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. It operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners' insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, The Travelers Companies’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

The Travelers Companies’s stock is valued at $193.58 at 18:21 EST, under its 52-week high of $194.51 and way higher than its 52-week low of $157.33.

More news about The Travelers Companies.

23. Tyson Foods (TSN)

Shares of Tyson Foods jumped 8.97% in from $49.74 to $54.20 at 18:21 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company processes live fed cattle and hogs; fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully cooked meats; raises and processes chickens into fresh, frozen, and value-added chicken products, including breaded chicken strips, nuggets, patties, and other ready-to-fix or fully cooked chicken parts; and supplies poultry breeding stock. It also manufactures and markets frozen and refrigerated food products, including ready-to-eat sandwiches, flame-grilled hamburgers, Philly steaks, pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, flour and corn tortilla products, appetizers, snacks, prepared meals, ethnic foods, side dishes, meat dishes, breadsticks, and processed meats under the Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp, and State Fair brands. The company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors who serve restaurants and food service operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors, as well as through independent brokers and trading companies. The company was founded in 1935 and is headquartered in Springdale, Arkansas.

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.8%, now sitting on 52.88B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tyson Foods’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 56.5% and positive 1025% for the next.

Yearly Top and Bottom Value

Tyson Foods’s stock is valued at $54.20 at 18:21 EST, way below its 52-week high of $66.79 and way higher than its 52-week low of $44.94.

Previous days news about Tyson Foods

  • Tyson foods (tsn) registers a bigger fall than the market: important facts to note. According to Zacks on Wednesday, 3 January, "The investment community will be paying close attention to the earnings performance of Tyson Foods in its upcoming release. ", "In terms of valuation, Tyson Foods is currently trading at a Forward P/E ratio of 24.6. "

More news about Tyson Foods.

24. Yelp (YELP)

Shares of Yelp rose 4.75% in from $44.43 to $46.54 at 18:21 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is dropping 0.02% to $16,715.71, after four successive sessions in a row of losses.

Yelp Inc. operates a platform that connects consumers with local businesses in the United States and internationally. The company's platform covers various local business categories, including restaurants, shopping, beauty and fitness, health, and other categories, as well as home, local, auto, professional, pets, events, real estate, and financial services. It provides free and paid advertising products to businesses, which include cost-per-click search advertising and multi-location Ad products, as well as enables businesses to deliver targeted search advertising to local audiences; and business listing page products. The company also offers other services comprising Yelp Guest Manager, a subscription-based suite of front-of-house management tools for restaurants, nightlife and certain other venues, which include online reservations, a waitlist management solution that allows consumers to check wait times and join waitlists remotely as well as through hostless kiosks, and seating and server rotation management tools; Yelp Knowledge program that offers business owners local analytics and insights through access to its historical data and other proprietary content; and Yelp Fusion, which offers free and paid access to content and data for consumer-facing enterprise use through publicly available APIs. In addition, it provides content licensing, as well as allows third-party data providers to update and manage business listing information on behalf of businesses. Further, the company offers its products directly through its sales force; indirectly through partners; and online through its website and business app, as well as non-advertising partner arrangements. It has partnership with Grubhub for providing consumers with a service to place food orders for pickup and delivery. The company was incorporated in 2004 and is headquartered in San Francisco, California.

Yearly Top and Bottom Value

Yelp’s stock is valued at $46.54 at 18:21 EST, under its 52-week high of $48.99 and way above its 52-week low of $25.85.

Volatility

Yelp’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.96%, a positive 0.25%, and a positive 1.35%.

Yelp’s highest amplitude of average volatility was 1.13% (last week), 1.02% (last month), and 1.35% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Yelp’s stock is considered to be overbought (>=80).

More news about Yelp.

25. Raymond James Financial (RJF)

Shares of Raymond James Financial rose 4.86% in from $105.41 to $110.53 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.02% to $16,715.71, after four consecutive sessions in a row of losses.

Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe. The Private Client Group segment offers investment services, portfolio management services, insurance and annuity products, and mutual funds; support to third-party product partners, including sales and marketing support, as well as distribution and accounting, and administrative services; margin loans; securities borrowing and lending services; diversification strategies and alternative investment products; and custodial, trade execution, research, and other support and services. The Capital Markets segment provides investment banking services, such as equity and debt underwriting, and merger and acquisition advisory services; and fixed income and equity brokerage services. This segment also offers institutional sales, securities trading, equity research, and the syndication and management of investments in low-income housing funds and funds of a similar nature. The Asset Management segment provides asset management, portfolio management, and related administrative services to retail and institutional clients; and administrative support services, such as record-keeping. The Bank segment offers various types of loans, including securities-based, commercial and industrial, commercial real estate and construction, real estate investment trust, residential mortgage, and tax-exempt loans; insured deposit accounts; retail and corporate deposit; and liquidity management products and services. The Other segment is involved in the private equity investments comprising invests in third-party funds. Raymond James Financial, Inc. was founded in 1962 and is headquartered in Saint Petersburg, Florida.

Sales Growth

Raymond James Financial’s sales growth for the current quarter is 4.7%.

Yearly Top and Bottom Value

Raymond James Financial’s stock is valued at $110.53 at 18:21 EST, below its 52-week high of $120.73 and way above its 52-week low of $82.00.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 1.7% and positive 9.9% for the next.

More news about Raymond James Financial.

26. Fastly (FSLY)

Shares of Fastly fell 6.38% in from $17.41 to $16.30 at 18:21 EST on Thursday, after five consecutive sessions in a row of losses. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

More news about Fastly.

27. Unilever (UL)

Shares of Unilever jumped 1.75% in from $47.99 to $48.83 at 18:21 EST on Thursday, after two successive sessions in a row of gains. NYSE is falling 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Unilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products, which includes the vitamins, minerals, and supplements. Personal Care segment offers skin cleansing products comprising soap and shower, deodorant and oral care products, such as toothpaste, toothbrush, and mouthwash products. Home Care segment engages in the sale of fabric care including washing powders and liquids, and rinse conditioners; and home and hygiene, fabric enhancers, water and air wellness products. Nutrition segment provides the sale of scratch cooking aids, which includes soups, bouillons, and seasonings; dressings products, such as mayonnaise and ketchup; and beverages and functional nutrition products including Horlicks and Boost, as well as tea products. Ice Cream segment offers ice cream products including in-home and out-of-home ice creams. It offers its products under the AXE, Bango, Ben & Jerry's, Cif, Comfort, Domestos, Dove, Equilibra, Hellmann's, Knorr, LUX, Lifebuoy, Liquid I.V., Love Beauty & Planet, Magnum, OLLY, OMO, Onnit, Rexona, Seventh Generation, SmartPants, Sunsilk, The Vegetarian Butcher, Vaseline, and Wall's brands. The company was founded in 1860 and is headquartered in London, the United Kingdom.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Unilever’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 60.88B for the twelve trailing months.

Moving Average

Unilever’s value is higher than its 50-day moving average of $47.83 and below its 200-day moving average of $50.73.

Volatility

Unilever’s last week, last month’s, and last quarter’s current intraday variation average was 0.02%, 0.05%, and 0.61%.

Unilever’s highest amplitude of average volatility was 0.02% (last week), 0.52% (last month), and 0.61% (last quarter).

More news about Unilever.

28. Energy Transfer (ET)

Shares of Energy Transfer rose 3.18% in from $13.53 to $13.96 at 18:21 EST on Thursday, after three sequential sessions in a row of gains. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

Energy Transfer LP provides energy-related services. The company owns and operates approximately 11,600 miles of natural gas transportation pipeline, and three natural gas storage facilities in Texas and two natural gas storage facilities located in the state of Texas and Oklahoma; and 19,945 miles of interstate natural gas pipeline. It also sells natural gas to electric utilities, independent power plants, local distribution and other marketing companies, and industrial end-users. The company owns and operates natural gas gathering and natural gas liquid (NGL) pipeline, processing plant, and treating and conditioning facilities in Texas, New Mexico, West Virginia, Pennsylvania, Ohio, Oklahoma, Arkansas, Kansas, and Louisiana; natural gas gathering, oil pipeline, and oil stabilization facilities in South Texas; and a natural gas gathering system in Ohio, as well as transport and supplies water to natural gas producer in Pennsylvania. It owns approximately 5,650 miles of NGL pipeline; NGL fractionation facilities; NGL storage facilities with working storage capacity of approximately 58 million barrels (MMBbls); and other NGL storage assets and terminal with an aggregate storage capacity of approximately 25 MMBbls. The company provides crude oil transportation, terminalling, acquisition, and marketing activities; and sells and distributes gasoline, middle distillate, and motor fuels and other petroleum product. It offers natural gas compression service; carbon dioxide and hydrogen sulfide removal service; and manages coal and natural resources properties, as well as sells standing timber, leases coal-related infrastructure facilities, collects oil and gas royalty, and generate electrical power. The company was formerly known as Energy Transfer Equity, L.P. and changed its name to Energy Transfer LP in October 2018. Energy Transfer LP was founded in 1996 and is headquartered in Dallas, Texas.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Energy Transfer’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 9.6%, now sitting on 78.55B for the twelve trailing months.

More news about Energy Transfer.

29. LyondellBasell (LYB)

Shares of LyondellBasell rose 3.77% in from $92.91 to $96.41 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.02% to $16,715.71, after four successive sessions in a row of losses.

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and Polyolefins—Americas; Olefins and Polyolefins—Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products, polyethylene, and polypropylene; and propylene oxide and derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomer, acetyls, ethylene oxide, and ethylene glycol. In addition, the company produce and markets compounding and solutions including polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders, and advanced polymers including catalloy and polybutene-1; and refines heavy, high-sulfur crude oil and other crude oils, as well as refined products, including gasoline and distillates. Further, it develops and licenses chemical and polyolefin process technologies; manufactures and sells polyolefin catalysts; and serves food packaging, home furnishings, automotive components, and paints and coatings applications. The company was incorporated in 2009 and is headquartered in Houston, Texas.

Revenue Growth

Year-on-year quarterly revenue growth declined by 13.3%, now sitting on 41.38B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 6.2% and a drop 31.5% for the next.

Moving Average

LyondellBasell’s worth is above its 50-day moving average of $93.63 and higher than its 200-day moving average of $93.37.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LyondellBasell’s stock is considered to be oversold (<=20).

More news about LyondellBasell.

30. Fox Corporation (FOXA)

Shares of Fox Corporation rose 2.24% in from $29.42 to $30.08 at 18:21 EST on Thursday, following the last session’s downward trend. NASDAQ is sliding 0.56% to $14,510.30, after four successive sessions in a row of losses.

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies, virtual multi-channel video programming distributors, and other digital platforms primarily in the U.S. Television segment produces, acquires, markets, and distributes programming through the FOX broadcast network, advertising supported video-on-demand service Tubi, and power broadcast television stations including duopolies and other digital platform; and engages in production of content for company and third parties. Other, Corporate and Eliminations segment comprises the FOX Studio Lot which provides television and film production services including office space, studio operation services, and facility operations; and Credible, a U.S. consumer finance marketplace. The company was incorporated in 2018 and is headquartered in New York, New York.

Moving Average

Fox Corporation’s value is above its 50-day moving average of $30.07 and under its 200-day moving average of $32.02.

More news about Fox Corporation.

31. KeyCorp (KEY)

Shares of KeyCorp rose 9.64% in from $13.17 to $14.44 at 18:21 EST on Thursday, after two successive sessions in a row of losses. NYSE is dropping 0.02% to $16,715.71, after four successive sessions in a row of losses.

KeyCorp operates as the holding company for KeyBank National Association that provides various retail and commercial banking products and services in the United States. It operates in two segments, Consumer Bank and Commercial Bank. The company offers various deposits, investment products and services; and personal finance and financial wellness, student loan refinancing, mortgage and home equity, lending, credit card, treasury, business advisory, wealth management, asset management, investment, cash management, portfolio management, and trust and related services to individuals and small and medium-sized businesses. It also provides a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans comprising consumer, energy, healthcare, industrial, public sector, real estate, and technology loans for middle market clients. In addition, the company offers community development financing, securities underwriting, brokerage, and investment banking services. The company was founded in 1849 and is headquartered in Cleveland, Ohio.

Sales Growth

KeyCorp’s sales growth is negative 18.1% for the present quarter and negative 13.3% for the next.

More news about KeyCorp.

32. Internationa Flavors & Fragrances (IFF)

Shares of Internationa Flavors & Fragrances rose 4.23% in from $76.35 to $79.58 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through four segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds; savory products that includes soups, sauces, meat, fish, poultry, snacks, etc.; beverages, such as juice drinks, carbonated or flavored beverages, spirits, etc.; sweets that includes bakery products, candy, cereal, chewing gum, etc.; and dairy products, such as yogurt, ice cream, cheese, etc. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.

More news about Internationa Flavors & Fragrances.

33. Novartis AG (NVS)

Shares of Novartis AG jumped 8.47% in from $97.17 to $105.40 at 18:21 EST on Thursday, after five consecutive sessions in a row of gains. NYSE is dropping 0.02% to $16,715.71, after four successive sessions in a row of losses.

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Novartis AG’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 9.2% and 11.1%, respectively.

Moving Average

Novartis AG’s worth is higher than its 50-day moving average of $96.21 and higher than its 200-day moving average of $98.56.

Sales Growth

Novartis AG’s sales growth is negative 8.6% for the ongoing quarter and negative 11.4% for the next.

More news about Novartis AG.

34. Public Service Enterprise Group (PEG)

Shares of Public Service Enterprise Group fell 1.4% in from $62.82 to $61.94 at 18:21 EST on Thursday, after five sequential sessions in a row of gains. NYSE is sliding 0.02% to $16,715.71, after four sequential sessions in a row of losses.

Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in Mid-Atlantic United States. The company operates through PSE&G and PSEG Power. The PSE&G segment transmits electricity; distributes electricity and gas to residential, commercial, and industrial customers, as well as invests in solar generation projects, and energy efficiency and related programs; and offers appliance services and repairs. As of December 31, 2022, it had electric transmission and distribution system of 25,000 circuit miles and 864,000 poles; 55 switching stations with an installed capacity of 39,653 megavolt-amperes (MVA), and 235 substations with an installed capacity of 9,735 MVA; four electric distribution headquarters and five electric sub-headquarters; and 18,000 miles of gas mains, 12 gas distribution headquarters, two sub-headquarters, and one meter shop, as well as 56 natural gas metering and regulating stations. Public Service Enterprise Group Incorporated was incorporated in 1985 and is based in Newark, New Jersey.

More news about Public Service Enterprise Group.

35. Southern Company (SO)

Shares of Southern Company jumped 0.85% in from $71.55 to $72.16 at 18:21 EST on Thursday, after two successive sessions in a row of gains. NYSE is sliding 0.02% to $16,715.71, after four successive sessions in a row of losses.

The Southern Company, through its subsidiaries, engages in the generation, transmission, and distribution of electricity. It operates through three segments: Gas Distribution Operations, Gas Pipeline Investments, and Gas Marketing Services. The company also develops, constructs, acquires, owns, and manages power generation assets, including renewable energy projects and sells electricity in the wholesale market; and distributes natural gas in Illinois, Georgia, Virginia, and Tennessee, as well as provides gas marketing services, gas distribution operations, and gas pipeline investments operations. In addition, it constructs, operates, and maintains 77,591 miles of natural gas pipelines and 14 storage facilities with total capacity of 157 Bcf to provide natural gas to residential, commercial, and industrial customers. It serves approximately 8.8 million electric and gas utility customers. Further, the company offers digital wireless communications and fiber optics services. The Southern Company was incorporated in 1945 and is headquartered in Atlanta, Georgia.

Volatility

Southern Company’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.49%, a negative 0.03%, and a positive 0.89%.

Southern Company’s highest amplitude of average volatility was 0.55% (last week), 0.94% (last month), and 0.89% (last quarter).

Sales Growth

Southern Company’s sales growth is 9.8% for the current quarter and 10.9% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 16.7%, now sitting on 26.25B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Southern Company’s stock is considered to be oversold (<=20).

More news about Southern Company.

Leave a Reply

Your email address will not be published. Required fields are marked *